Jpmorgan Chase & CO Nutri Band Inc. Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Nutri Band Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 12 shares of NTRB stock, worth $70. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 9
33.33%
Holding current value
$70
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NTRB
# of Institutions
16Shares Held
258KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA86.8KShares$511,2520.0% of portfolio
-
Geode Capital Management, LLC Boston, MA58.6KShares$344,9830.0% of portfolio
-
Royal Bank Of Canada Toronto, A635.1KShares$206,5030.0% of portfolio
-
State Street Corp Boston, MA17.3KShares$101,6960.0% of portfolio
-
Virtu Financial LLC New York, NY12.9KShares$75,7570.0% of portfolio
About NutriBand Inc.
- Ticker NTRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,803,260
- Market Cap $46M
- Description
- Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...